STIRLING, DAVID I,CHAN, KYLE W H,HARIRI, ROBERT J,MOUTOUH-DE PARSEVAL, LAURE A
申请号：
NZ59379203
公开号：
NZ593792A
申请日:
2003.04.13
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
Patent No. 593792 Disclosed is the use of a composition in the preparation of a medicament for treating or preventing inflammation in an individual, wherein said composition comprises a therapeutically effective amount of stem or progenitor cells, wherein said stem or progenitor cells have been contacted with an amino-substituted thalidomide analog under conditions under which said stem or progenitor cells differentiate, wherein said cells are not totipotent, and wherein when said stem or progenitor cells are CD34+ or CD133+ hematopoietic stem cells, said inflammation is not neutropenia, chronic granulomatous disease, or infection.
